background
cat
felin
caliciviru
fcv
relat
symptom
commonli
present
veterinari
practition
variou
clinic
manifest
attribut
fcv
ie
upper
respiratori
tract
diseas
urtd
oral
ulcer
gingivostomat
limp
syndrom
virul
system
diseas
addit
healthi
cat
shed
fcv
aim
studi
investig
frequenc
fcv
cat
fcvrelat
symptom
healthi
cat
switzerland
assess
risk
protect
factor
infect
signal
hous
condit
vaccin
coinfect
urtdassoci
pathogen
address
associ
clinic
symptom
fcv
infect
result
oropharyng
nasal
conjunctiv
swab
collect
veterinari
practic
fcvsuspect
healthi
cat
origin
canton
switzerland
sampl
test
fcv
use
viru
isol
reversetranscript
realtim
quantit
polymeras
chain
reaction
qpcr
felin
mycoplasma
feli
chlamydophila
feli
bordetella
bronchiseptica
use
realtim
qpcr
within
two
popul
fcvsuspecthealthi
observ
pcr
preval
fcv
c
feli
b
bronchiseptica
feli
coinfect
thereof
base
multivari
regress
model
amongst
fcvsuspect
cat
odd
ratio
confid
interv
coinfect
feli
group
hous
intact
reproduct
statu
found
risk
factor
fcv
infect
healthi
cat
intact
reproduct
statu
group
hous
found
associ
fcv
infect
base
univari
approach
fcvsuspect
cat
found
significantli
less
often
fcvposit
vaccin
oral
ulcer
saliv
gingiv
stomat
classic
sign
urtd
significantli
associ
fcv
infect
p
conclus
fcv
detect
less
half
cat
judg
fcvsuspect
veterinari
practition
clinic
diagnosi
fcvrelat
symptom
revisit
fcv
infect
present
healthi
cat
underlin
import
asymptomat
carrier
fcv
epidemiolog
reduc
fcvrelat
problem
multicat
environ
reduct
group
size
addit
gener
recommend
vaccin
advoc
felin
caliciviru
fcv
rna
viru
occur
worldwid
domest
cat
exot
felid
fcv
infect
commonli
associ
oral
ulcer
saliv
clinic
syndrom
attribut
fcv
infect
includ
chronic
stomat
limp
syndrom
year
ago
highli
virul
system
fcv
infect
associ
fatal
diseas
report
sever
countri
initi
north
america
subsequ
europ
outbreak
sever
fcv
infect
associ
edema
skin
ulcer
also
describ
cat
switzerland
willi
et
al
submit
public
fcv
also
assign
upper
respiratori
tract
diseas
urtd
complex
cat
flu
addit
fcv
least
four
pathogen
shown
associ
syndrom
includ
felin
herpesviru
type
mycoplasma
feli
chlamydophila
feli
bordetella
bronchiseptica
cat
urtd
commonli
present
veterinari
practition
show
symptom
lethargi
pyrexia
anorexia
sneez
nasal
discharg
ocular
discharg
conjunct
kerat
convent
nest
realtim
reversetranscriptas
quantit
polymeras
chain
reaction
rtqpcr
assay
develop
amplifi
fcvspecif
rna
clinic
specimen
high
genet
variabl
fcv
hamper
diagnost
sensit
fcvspecif
molecular
assay
viru
isol
advoc
altern
diagnost
tool
method
routin
avail
viru
isol
less
sensit
genom
variat
method
might
fail
due
viru
inactiv
transport
thu
result
reduc
diagnost
sensit
fcv
vaccin
shown
efficaci
protect
cat
develop
sever
diseas
howev
induc
steril
immun
moreov
commerci
avail
vaccin
base
fcv
strain
ie
fcv
mani
decad
therefor
protect
potenti
fcv
vaccin
differ
circul
fcv
isol
controversi
discuss
recent
year
effort
made
identif
new
vaccin
strain
broader
crossreact
develop
bior
polyval
vaccin
inclus
local
fcv
isol
along
line
vaccin
contain
two
novel
fcv
strain
becom
commerci
avail
switzerland
fcv
despit
introduct
fcv
vaccin
sever
decad
ago
cat
fcvrelat
symptom
still
commonli
present
veterinari
practic
presumpt
clinic
diagnosi
reli
presenc
fcvrelat
symptom
howev
clinic
sign
induc
fcv
urtdassoci
pathogen
overlap
coinfect
common
molecular
assay
detect
urtdassoci
pathogen
clinic
specimen
might
aid
diagnosi
asymptomat
carrier
report
result
molecular
assay
must
interpret
togeth
clinic
present
aim
studi
investig
frequenc
fcv
cat
suspect
fcv
infect
veterinari
practition
clinic
healthi
cat
switzerland
address
potenti
risk
protect
factor
infect
group
cat
signal
hous
condit
vaccin
coinfect
urtdassoci
pathogen
furthermor
associ
number
differ
clinic
symptom
fcv
infect
assess
total
clinic
diseas
cat
symptom
compat
fcv
infect
fcvsuspect
cat
clinic
healthi
cat
enrol
studi
part
larg
fcv
project
goal
obtain
collect
fcv
isol
symptomat
asymptomat
cat
switzerland
genet
serolog
studi
popul
sampl
veterinari
surgeon
switzerland
septemb
april
goal
includ
sampl
origin
randomli
select
veterinari
practic
differ
geograph
region
canton
switzerland
ten
fcvsuspect
five
healthi
cat
per
practic
one
cat
per
owner
eg
household
catteri
includ
veterinarian
obtain
inform
consent
cat
owner
sampl
taken
part
diagnost
workup
routin
test
felvfiv
healthi
cat
result
provid
veterinarian
cat
owner
ethic
approv
necessari
studi
complianc
swiss
regul
veterinari
practic
abl
collect
suffici
number
sampl
within
given
time
frame
eight
month
support
second
third
veterinari
practic
within
canton
result
particip
veterinari
practic
canton
enrol
cat
origin
canton
switzerland
fig
particip
veterinarian
provid
list
follow
fcvrelat
clinic
sign
sneez
nasal
andor
ocular
discharg
conjunct
caudal
stomat
chronic
stomat
andor
gingiv
lingual
oral
ulcer
pneumonia
shift
lame
combin
fever
cutan
edema
dermal
ulcer
face
andor
limb
clinic
sign
select
base
guidelin
felin
caliciviru
infect
european
advisori
board
cat
diseas
abcd
recent
public
written
instruct
contain
illustr
recogn
fcvassoci
clinic
sign
describ
collect
ship
sampl
inclus
criteria
clinic
healthi
cat
absenc
clinic
sign
base
anamnesi
clinic
examin
particip
veterinarian
cat
vaccin
fcv
c
feli
within
day
prior
sampl
collect
younger
eight
week
exclud
record
demograph
data
enrol
anim
veterinarian
fill
questionnair
cat
visit
clinic
avoid
interview
bia
particip
veterinarian
receiv
written
instruct
fill
questionnair
similar
questionnair
use
earlier
studi
questionnair
compris
differ
section
geograph
data
address
cat
owner
demograph
data
age
sex
reproduct
statu
breed
cat
husbandri
data
type
husbandri
privat
home
farm
cat
breeder
feral
cat
catteri
number
cat
per
household
outdoor
access
contact
dog
kennel
cough
data
vaccin
histori
accord
clinic
record
vaccin
card
vaccin
statu
parvoviru
date
primari
immun
booster
immun
vaccin
use
vaccin
statu
felin
leukemia
viru
felv
date
last
felv
vaccin
retroviru
statu
felv
andor
felin
immunodefici
viru
fiv
test
result
date
test
data
medic
histori
antivir
antibiot
immunosuppress
treatment
time
sampl
collect
two
month
collect
result
clinic
examin
oropharyng
cytobrush
well
nasal
conjunctiv
cotton
swab
collect
cat
sampl
collect
materi
provid
investig
conjunctiv
swab
collect
prior
diagnost
treatment
fluorescein
applic
cytobrush
swab
place
steril
safelock
eppendorf
tube
contain
steril
viral
transport
medium
medium
consist
ml
bidistil
steril
water
ml
hepesbuff
sigmaaldrich
chemi
gmbh
steinheim
germani
ml
dulbecco
mem
biochrom
berlin
germani
ml
heat
inactiv
fetal
calf
serum
charg
origin
south
america
bio
concept
allschwil
switzerland
ml
antibioticantimycot
gibco
life
technolog
lucern
switzerland
ml
sodium
hydrogen
bicarbon
merck
darmstadt
germani
ph
adjust
use
sodium
hydroxid
merck
sampl
store
prior
ship
laboratori
prioriti
mail
sampl
process
within
h
collect
sampl
process
total
nucleic
acid
tna
extract
upon
arriv
cytobrush
swab
incub
min
cytobrush
swab
turn
upsid
centrifug
min
g
sampl
patient
oropharyng
cytobrush
nasal
conjunctiv
swab
pool
subsequ
divid
follow
two
aliquot
use
tna
extract
use
viru
isol
tna
extract
perform
use
sampl
cell
cultur
supernat
magna
pure
lc
roch
diagnost
ag
rotkreuz
switzerland
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
follow
manufactur
instruct
batch
extract
neg
control
consist
pb
use
monitor
crosscontamin
tna
store
qpcr
analysi
viru
isol
sampl
filter
filtropur
syring
filter
sarstedt
germani
incub
confluent
crandellre
felin
kidney
cell
plate
tpp
tissu
cultur
testplat
tpp
techno
plastic
product
ag
trasadingen
switzerland
cultur
use
rpmi
medium
sigmaaldrich
chemi
gmbh
supplement
heat
inactiv
fetal
calf
serum
invitrogen
basel
switzerland
mm
lglutamin
gibco
life
technolog
antibioticantimycot
gibco
life
technolog
sampl
cultur
neg
mediumonli
control
run
parallel
sampl
incub
cell
two
hour
complet
medium
ad
cell
fed
daili
evalu
presenc
cytopath
effect
soon
cytopath
effect
becam
visibl
maximum
seven
day
supernat
collect
tna
extract
storag
use
tna
extract
could
perform
day
collect
lysi
buffer
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
ad
supernat
mixtur
store
recommend
manufactur
tna
extract
cell
cultur
supernat
maximum
h
storag
realtim
qpcr
assay
current
studi
run
tna
end
volum
posit
neg
control
run
rtqpcr
qpcr
assay
oligonucleotid
synthet
microsynth
ag
balgach
switzerland
qpcr
assay
run
abi
realtim
pcr
system
appli
biosystem
rotkreuz
switzerland
quantit
analys
ct
valu
use
fcv
two
previous
describ
fcv
realtim
taqman
rtqpcr
assay
use
assay
optim
prior
start
experi
fcv
rtqpcr
reaction
contain
x
one
step
rtqpcr
mastermix
low
rox
eurogentec
sera
belgium
nm
forward
primer
nm
revers
primer
nm
probe
nucleasefre
water
gibco
life
technolog
euroscript
eurogentec
temperatur
profil
min
follow
min
cycl
follow
min
fcv
rtqpcr
reaction
contain
superscript
iiirt
platinum
taq
mix
invitrogen
life
technolog
nm
forward
primer
nm
revers
primer
nm
probe
rox
dye
rnase
inhibitor
promega
switzerland
plu
rnase
inhibitor
promega
nucleasefre
water
gibco
life
technolog
temperatur
profil
min
follow
min
cycl
follow
sampl
tna
swabcytobrush
tna
cell
cultur
supernat
analyz
rtqpcr
assay
cat
test
posit
least
one
four
rtqpcr
run
categor
fcvposit
fcv
rtqpcr
rtqpcr
swabscytobrush
viru
isol
tna
swabcytobrush
cat
also
test
c
feli
b
bronchiseptica
feli
qpcr
use
previous
describ
method
moreov
sampl
also
test
felv
fiv
viral
rna
rtqpcr
infect
lead
increas
suscept
infect
associ
inflammatori
oral
diseas
three
sampl
fcvsuspect
cat
could
analyz
b
bronchiseptica
feli
felv
fiv
lack
materi
statist
analysi
perform
util
freeli
avail
softwar
program
r
version
separ
fcvsuspect
clinic
healthi
cat
descript
statist
frequenc
male
femal
cat
median
confid
interv
ci
age
proport
dichotom
variabl
ci
base
binomi
distribut
present
regress
model
appli
assess
predictor
age
year
sex
male
femal
reproduct
statu
intact
neuter
pedigre
ye
outdoor
access
live
group
least
four
cat
vaccin
receiv
primari
immun
receiv
immunosuppress
antimicrobi
andor
antivir
treatment
coinfect
feli
c
feli
andor
b
bronchiseptica
significantli
associ
outcom
fcv
infect
univari
regress
outcom
fcv
perform
odd
ratio
wald
confid
interv
shown
due
presenc
miss
valu
reduc
number
complet
case
mean
cat
inform
predictor
fcvsuspect
anim
clinic
healthi
anim
miss
valu
imput
packag
missforest
separ
fcvsuspect
clinic
healthi
cat
imput
done
iter
base
random
forest
approach
util
imput
data
set
multivari
logist
regress
perform
packag
mass
model
built
follow
two
differ
approach
first
variabl
pvalu
univari
regress
consid
differ
model
includ
interact
term
model
select
base
aic
akaik
inform
criterion
lower
valu
least
consid
indic
better
model
fit
case
model
differ
smaller
parsimoni
model
chosen
second
stepwis
regress
approach
direct
appli
includ
variabl
irrespect
pvalu
univari
approach
interact
term
diagnost
plot
assess
robust
final
model
result
present
odd
ratio
wald
confid
interv
fcv
load
swabcytobrush
sampl
compar
two
group
use
mannwhitney
utest
p
mwu
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
map
produc
use
qgi
geograph
inform
system
v
canton
boundari
provid
swiss
feder
offic
topographi
summari
statist
variabl
use
statist
analysi
fcvsuspect
healthi
cat
present
tabl
includ
pcr
result
urtdassoci
pathogen
fcv
infect
detect
ci
fcvsuspect
cat
ci
healthi
cat
among
fcvsuspect
healthi
cat
ci
ci
respect
coinfect
test
urtdassoci
pathogen
summari
among
coinfect
fcvsuspect
cat
posit
two
three
four
pathogen
among
coinfect
healthi
cat
posit
two
three
pathogen
detail
see
addit
file
ci
fcvsuspect
cat
none
test
urtdassoci
pathogen
detect
five
cat
four
fcvsuspect
one
healthi
cat
ci
test
posit
either
felv
fiv
low
preval
fiv
felv
infect
consid
statist
analysi
approxim
two
third
cat
live
group
cat
tabl
detail
number
cat
per
group
frequenc
fcv
infect
shown
addit
file
major
fcvsuspect
ci
healthi
cat
ci
vaccin
fcvsuspect
ci
healthi
cat
ci
receiv
primari
immun
defin
minimum
two
vaccin
two
six
week
apart
vaccin
strain
tabl
group
cat
vaccin
strain
frequent
use
primari
immun
fcv
fcvsuspect
cat
ci
healthi
cat
ci
follow
fcv
fcvsuspect
cat
ci
healthi
cat
ci
small
number
cat
vaccin
vaccin
strain
vaccin
strain
consid
statist
analysi
base
univari
regress
model
fcvsuspect
cat
intact
reproduct
statu
live
group
least
four
cat
coinfect
feli
vaccin
primari
immun
found
significantli
associ
fcv
infect
tabl
former
three
predictor
found
risk
factor
approxim
doubl
chanc
fcv
infect
intact
versu
neuter
live
group
least
four
cat
coinfect
feli
vaccin
receiv
primari
immun
found
protect
factor
reduc
chanc
fcv
infect
approxim
contrast
amongst
clinic
healthi
cat
vaccin
predictor
significantli
associ
fcv
infect
tabl
similarli
fcvsuspect
cat
intact
reproduct
statu
live
group
least
four
cat
found
risk
factor
albeit
higher
odd
ratio
consider
larger
confid
interv
fcvsuspect
cat
detail
miss
valu
univari
regress
complet
case
imput
data
set
present
addit
file
wherea
pvalu
obtain
origin
data
imput
data
similar
pvalu
complet
case
analys
differ
slightli
base
multivari
regress
model
fcvsuspect
anim
intact
reproduct
statu
live
group
least
four
cat
coinfect
feli
remain
final
model
odd
ratio
reduc
least
compar
univari
result
tabl
base
stepwis
regress
predictor
outdoor
access
addit
found
risk
factor
fcv
infect
data
shown
none
variabl
describ
vaccin
found
signific
multivari
model
regard
clinic
healthi
cat
intact
reproduct
statu
live
group
least
four
cat
remain
final
model
higher
odd
ratio
larger
confid
interv
fcvsuspect
cat
stepwis
regress
possibl
group
cat
due
lack
converg
clinic
sign
cat
chosen
veterinari
practition
fcvrelat
symptom
shown
tabl
approxim
half
fcvsuspect
cat
gingiv
classic
sign
urtd
primari
immun
defin
two
subsequ
vaccin
within
week
vaccin
strain
e
posit
realtim
qpcrrtqpcr
nasal
discharg
ocular
discharg
conjunct
sneez
present
approxim
one
third
cat
exhibit
stomat
caudal
stomat
demonstr
oral
lingual
ulcer
found
swollen
joint
lame
skin
ulcer
cutan
edema
gingiv
stomat
caudal
stomat
saliv
oral
lingual
ulcer
significantli
associ
fcv
infect
tabl
contrast
nasal
ocular
discharg
sneez
significantli
less
common
fcv
pcrposit
fcv
pcrneg
cat
fcv
load
sampl
materi
compar
fcvposit
diseas
fcvposit
healthi
cat
fcv
load
higher
diseas
cat
although
statist
signific
reach
fcv
rtqpcr
p
mwu
fig
cat
germani
chronic
gingivostomat
ci
present
studi
cat
judg
fcvsuspect
veterinari
practition
base
written
instruct
list
fcvrelat
symptom
describ
literatur
interestingli
cat
suffer
gingiv
urtdrel
symptom
commonli
select
veterinarian
howev
gingiv
stomat
caudal
stomat
saliv
oral
lingual
ulcer
significantli
associ
fcv
infect
classic
sign
urtd
sneez
nasal
ocular
discharg
contrast
sneez
nasal
ocular
discharg
significantli
less
common
fcvposit
cat
compar
fcvneg
cat
find
contrast
earlier
studi
fcv
infect
significantli
associ
felin
respiratori
tract
diseas
howev
accord
result
bannasch
cowork
found
among
five
pathogen
associ
urtd
examin
present
studi
import
contributor
urtd
mycoplasma
speci
c
feli
acut
fcv
known
induc
vesicular
diseas
typic
manifest
oral
lingual
ulcer
ocular
nasal
discharg
rare
report
experiment
fcv
infect
chronic
fcv
infect
strongli
associ
presenc
gingivostomat
although
exact
pathogenesi
diseas
still
unknown
data
suggest
clinic
diagnosi
fcv
infect
fcvrelat
symptom
reconsid
stringent
defin
diagnosi
confirm
molecular
test
need
note
rel
low
detect
rate
fcv
fcvsuspect
cat
could
also
attribut
limit
diagnost
sensit
appli
diagnost
assay
current
studi
criterion
fcvposit
base
presenc
least
one
posit
four
realtim
rtqpcr
run
two
differ
pcr
assay
perform
directli
sampl
materi
enrich
step
cell
cultur
approach
chosen
maxim
diagnost
sensit
howev
remark
high
genet
variabl
fcv
increas
likelihood
potenti
mismatch
primer
probe
bind
site
thu
lead
possibl
fail
realtim
pcr
amplif
interestingli
fcvsuspect
cat
test
neg
urtdassoci
pathogen
cat
noninfecti
etiolog
urtd
ie
neoplasia
foreign
bodi
primari
immunemedi
rhiniti
could
account
case
cat
noninfecti
urtd
clinic
indistinguish
cat
urtd
caus
infecti
agent
addit
detect
urtdassoci
pathogen
could
fail
due
sampl
degrad
transport
veterinari
practic
laboratori
avoid
minim
effect
sampl
present
studi
analyz
within
h
collect
final
diagnost
sensit
pcr
assay
could
hamper
genet
alter
pathogen
within
target
sequenc
appli
pcr
assay
howev
contrast
rna
virus
fcv
high
genet
variabl
necessarili
expect
c
feli
feli
b
bronchiseptica
approxim
healthi
cat
present
studi
test
pcrposit
fcv
proport
lower
fcv
report
earlier
studi
uk
ci
germani
ci
previous
report
import
rememb
cat
although
clinic
healthi
shedder
infecti
pathogen
relat
urtd
present
studi
risk
factor
analysi
perform
univari
multivari
regress
model
latter
perform
imput
data
set
due
miss
data
select
multivari
regress
approach
offer
contrast
univari
approach
possibl
adjust
confound
inevit
howev
remain
possibl
relev
confound
record
miss
valu
lead
subsequ
differ
sampl
size
model
differ
variabl
preclud
possibl
compar
model
fit
thu
data
set
imput
variabl
miss
valu
gener
although
result
pvalu
obtain
origin
imput
data
set
similar
univari
analysi
imput
may
potenti
includ
bia
two
modelbuild
approach
perform
fcvsuspect
cat
stepwis
approach
possibl
clinic
healthi
cat
assur
robust
final
model
although
found
signific
protect
factor
univari
model
statist
associ
vaccin
statu
primari
immun
vanish
multivari
analysi
one
reason
might
predictor
vaccin
statu
primari
immun
categori
ye
unknown
case
fcvsuspect
healthi
cat
respect
compris
number
differ
vaccin
vaccin
scheme
time
elaps
sinc
vaccin
thu
potenti
heterogen
actual
show
statist
associ
addit
fcv
vaccin
induc
steril
immun
although
shown
reduc
sever
clinic
sign
therefor
vaccin
protect
sole
judg
pcr
statu
cat
furthermor
crosssect
studi
rather
limit
assess
causal
relationship
especi
sinc
crosssect
approach
preval
estim
wherea
incid
would
relev
intact
reproduct
statu
live
group
least
four
cat
coinfect
feli
found
risk
factor
fcv
infect
three
factor
approxim
doubl
chanc
find
fcv
infect
number
interact
term
includ
interact
group
least
four
cat
feli
infect
vaccin
intact
reproduct
statu
test
potenti
associ
none
found
statist
signific
associ
fcv
intact
reproduct
statu
report
earlier
studi
although
clear
explan
given
associ
possibl
reason
postul
earlier
includ
hormon
effect
might
alter
replic
persist
viru
social
aggress
interact
intact
anim
associ
fcv
infect
hous
larg
group
cat
report
previou
studi
cat
kept
larg
group
expos
higher
infecti
pressur
compar
cat
live
smaller
group
high
plastic
fcv
genom
posit
select
immun
system
support
genom
mutat
lead
progress
evolut
fcv
variant
cat
group
cyclic
reinfect
previous
immun
cat
addit
strict
quarantin
measur
excel
hygien
challeng
guarante
larg
group
cat
therebi
favor
fcv
infect
breeder
risk
infect
relat
urtd
cat
also
risk
felin
infect
develop
felin
infecti
periton
clear
explan
given
associ
fcv
infect
feli
coinfect
possibl
reason
could
similar
transmiss
rout
pathogenesi
similar
risk
factor
infect
fcv
infect
often
report
occur
concurr
cat
coinfect
fcv
high
risk
develop
urtd
howev
associ
fcv
infect
coinfect
test
pathogen
c
feli
b
bronchiseptica
found
present
studi
differ
hous
categori
includ
privat
home
farm
breeder
feral
cat
catteri
record
studi
sinc
vast
major
cat
kept
privat
home
possibl
disentangl
effect
differ
hous
categori
variabl
breed
dichotom
pedigre
nonpedigre
cat
statist
analysi
number
cat
per
breed
small
absenc
statist
associ
therefor
preclud
potenti
associ
specif
breed
fcv
infect
exampl
fcvsuspect
main
coon
found
fcvinfect
suffer
gingivostomat
known
purebr
main
coon
predispos
develop
earli
sever
periodont
diseas
associ
fcv
infect
describ
thu
far
note
howev
fcvposit
main
coon
hous
group
data
shown
present
studi
fcvsuspect
healthi
cat
respect
vaccin
fcv
ie
receiv
vaccin
fcv
time
point
vaccin
rate
seem
higher
rate
estim
switzerland
accord
number
sold
vaccin
dose
swiss
cat
vaccin
thu
accord
number
proport
vaccin
cat
would
suffici
high
provid
protect
popul
herd
immun
within
sampl
popul
oppos
protect
vaccin
host
howev
present
studi
base
preselect
popul
cat
cat
receiv
proper
primari
immun
lack
necessari
booster
vaccin
leav
doubt
actual
level
protect
present
studi
assess
fcv
infect
cat
judg
fcvsuspect
veterinari
practition
clinic
healthi
cat
switzerland
fcv
infect
detect
less
half
fcvsuspect
cat
within
group
cat
infect
significantli
associ
gingiv
stomat
caudal
stomat
oral
lingual
ulcer
classic
sign
urtd
sneez
nasal
ocular
discharg
result
suggest
fcvrelat
symptom
critic
reassess
probabl
stringent
defin
fcv
infect
also
detect
healthi
cat
observ
underlin
import
asymptomat
shedder
fcv
epidemiolog
hous
larg
group
cat
among
risk
factor
fcv
infect
thu
problem
fcv
encount
multicat
environ
reduct
group
size
addit
gener
recommend
vaccin
quarantin
measur
incom
sick
cat
advoc
